Company Name: Vericel Corporation

Vericel Corporation is engaged in the development of patient specific expanded cellular therapies. The company’s autologous cell therapy products include:

  • Carticel®: Autologous chondrocyte implant designed to treat cartilage defects in the knee
  • Epicel®: Permanent skin replacement designed to treat deep dermal or full thickness burns that make up thirty percent or more of total body surface area

Ticker Symbol: VCEL (NASDAQ)

Company Website:

Social Media:

Vericel Corporation Facebook

Vericel Corporation LinkedIn

Headquarters: Cambridge, MA